Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2021

01-12-2021 | Systemic Therapy | ASO Author Reflections

ASO Author Reflections: Time to Treatment: A New Quality Metric in Breast Cancer Care?

Authors: Debra Pratt, MD, FACS, Stephen R. Grobmyer, MD, FACS

Published in: Annals of Surgical Oncology | Issue 13/2021

Login to get access

Excerpt

The time to treatment (TTT) for breast cancer has increased, even more for academic centers than for private hospitals.1 Multiple studies, using National Cancer Database (NCDB) data, have established that decreased patient survival is associated with delayed initiation of treatment.2,3
Literature
2.
go back to reference Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–9.CrossRef Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–9.CrossRef
3.
go back to reference Khorana AA, Tullio K, Elson P, et al. Time to initial cancer treatment in the United States and association with survival over time: an observational study. PLOS ONE. 2019;14:e0215108.CrossRef Khorana AA, Tullio K, Elson P, et al. Time to initial cancer treatment in the United States and association with survival over time: an observational study. PLOS ONE. 2019;14:e0215108.CrossRef
Metadata
Title
ASO Author Reflections: Time to Treatment: A New Quality Metric in Breast Cancer Care?
Authors
Debra Pratt, MD, FACS
Stephen R. Grobmyer, MD, FACS
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10169-w

Other articles of this Issue 13/2021

Annals of Surgical Oncology 13/2021 Go to the issue